🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicentre, randomized controlled trial evaluates the effect and safe...
Status
Recruiting
Location
Guangdong Provincial Hospital of Chinese Medicine
Start Date
2026-01-15
Trial ID
NCT07337096
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
The purpose of this study is to assess the efficacy and safety of platinum-...
Status
Completed
Location
Pacific Cancer Medical Center
Start Date
2020-09-11
Trial ID
NCT04205812
Treatments Being Tested
This pilot study is configured as a non-inferiority comparison of Performan...
Status
Recruiting
Location
Wake Forest Baptist Comprehensive Cancer Center
Start Date
2020-07-01
Trial ID
NCT04253964
Treatments Being Tested
The primary objective of this study is to compare the effect of zimberelima...
Status
Active Not Recruiting
Location
Innovative Clinical Research Institute
Start Date
2022-10-12
Trial ID
NCT05502237
Treatments Being Tested
This is an international, randomized, open-label, Phase 3 study designed to...
Status
Terminated
Location
Hospital Britanico
Start Date
2020-07-24
Trial ID
NCT04222972
Treatments Being Tested
The purpose of this study is to test if low dose radiation, which is routin...
Status
Terminated
Location
NYU Langone Health
Start Date
2023-01-24
Trial ID
NCT05691829
Treatments Being Tested
The primary objectives of this study were: to assess the safety and tolerab...
Status
Completed
Location
Mayo Clinic Phoenix
Start Date
2019-08-15
Trial ID
NCT04047862
This study aims to evaluate the major pathologic response (MPR) rate of neo...
Status
Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2026-01-10
Trial ID
NCT07410975
Treatments Being Tested
The aim of this study was to investigate that efficacy and safety of rh-end...
Status
Unknown
Location
Zhou Chengzhi
Start Date
2020-02-06
Trial ID
NCT04094909
Treatments Being Tested